Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzuken Co ( (JP:9987) ) has shared an announcement.
Suzuken Co., Ltd. reported variances between its forecasted and actual consolidated financial results for the six months ending September 30, 2025. While net sales were slightly below expectations, operating and ordinary profits exceeded forecasts due to effective cost management and strategic initiatives. The profit attributable to owners of the parent was significantly higher than anticipated, driven by extraordinary gains from the sale of investment securities. The company maintains its earnings forecast for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical distribution industry, focusing on the distribution of oncology and specialty drugs. It is listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
Average Trading Volume: 182,377
Technical Sentiment Signal: Buy
Current Market Cap: Yen337.7B
Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.